ng-nitroarginine methyl ester has been researched along with Adenoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Epifano, F; Fiorito, S; Genovese, S; Kochi, T; Mori, T; Moriwaki, H; Shimizu, M; Shirakami, Y; Tanaka, T | 1 |
1 other study(ies) available for ng-nitroarginine methyl ester and Adenoma
Article | Year |
---|---|
A newly synthesized compound, 4'-geranyloxyferulic acid-N(omega)-nitro-L-arginine methyl ester suppresses inflammation-associated colorectal carcinogenesis in male mice.
Topics: Adenocarcinoma; Adenoma; Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carcinogenesis; Cell Proliferation; Colorectal Neoplasms; Coumaric Acids; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Inflammation; Intestinal Mucosa; Male; Mice; Mice, Inbred ICR; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Nitroarginine; RNA-Binding Proteins | 2014 |